(A) Proliferation inhibition assay of M-PLL/siRNASur nanoparticles on 4T1 cells with or without NIR irradiation (n=6, mean±SD). (B) Representative cytotoxicity image of 4T1 cells incubated with PBS (a), naked siRNASur (b), M-PLL/siRNAN.C. (c), M-PLL/siRNASur (d) or M-PLL/siRNASur+NIR (e) by using calcein-AM (green, live cells) and propidium iodide (red, dead cells) staining method. Scale bar is 100 μm, magnification ×40. (C) Quantitatively apoptotic analysis of cells treated with different formulations by using Annexin V-FITC/PI staining assay. (D) Survivin protein levels in 4T1 cells after different treatment by ELISA method. Data were presented as nanogram of surviving protein per milligram of protein (n=3, mean±SD). **,aP<0.01 by comparing M-PLL/siRNASur (Laser off) with PBS and naked siRNASur, ***,bP<0.001 by comparing M-PLL/siRNASur (Laser on) with PBS and naked siRNASur and **,cP<0.01 by comparing M-PLL/siRNASur (Laser on) with M-PLL/siRNASur (Laser off).
Abbreviations: M-PLL, melanin-poly-L-lysine; NIR, near infrared; siRNA, small interference RNA; PBS, phosphate-buffered solution; siRNAN.C., siRNA of nonsense sequences; siRNASur, survivin-targeted siRNA; ELISA, enzyme-linked immunosorbent assay; PI, propidium iodide.